# Roflumilast TMS-EEG Plasticity

> **NCT04369547** · PHASE1 · WITHDRAWN · sponsor: **University of Calgary**

## Conditions studied

- Synaptic Plasticity

## Interventions

- **DEVICE:** Transcranial Magnetic Stimulation
- **DRUG:** Roflumilast
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04369547
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Resource limitations
- **Last updated:** 2021-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04369547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04369547, "Roflumilast TMS-EEG Plasticity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04369547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*